[Effectiveness of correcting radiation injuries of the thymic endocrine function by T-activin in conditions of reduced postradiation hypercorticism reaction]

Radiobiologiia. 1992 May-Jun;32(3):418-24.
[Article in Russian]

Abstract

T-activin administered to rats after exposure to whole-body 1.5 Gy neutron- and 6 Gy X-radiation increases considerably the thymosin-like serum activity, accelerates cellularity restoration in the thymus and spleen, but does not influence the survival rate. Ionol administered prior to X-irradiation reduces the postirradiation hypercorticism reaction and the indirect effect of radiation on lymphoid organs which it is responsible for. The combined injection of ionol and T-activin increases the thymosin-like serum activity and spleen cellularity to the highest possible level and increases the survival rate of rats from 24 to 64 per cent and the lifespan up to 6 days.

Publication types

  • Comparative Study
  • English Abstract

MeSH terms

  • Adjuvants, Immunologic / administration & dosage
  • Adjuvants, Immunologic / pharmacology*
  • Adjuvants, Immunologic / therapeutic use
  • Adrenocortical Hyperfunction / etiology
  • Adrenocortical Hyperfunction / prevention & control*
  • Animals
  • Butylated Hydroxytoluene / administration & dosage
  • Butylated Hydroxytoluene / pharmacology
  • Drug Therapy, Combination
  • Male
  • Peptides / administration & dosage
  • Peptides / pharmacology*
  • Peptides / therapeutic use
  • Radiation Dosage
  • Radiation Injuries, Experimental / drug therapy*
  • Radiation Injuries, Experimental / mortality
  • Rats
  • Thymosin / blood
  • Thymus Extracts / administration & dosage
  • Thymus Extracts / pharmacology*
  • Thymus Extracts / therapeutic use
  • Thymus Gland / drug effects*
  • Thymus Gland / radiation effects*
  • Time Factors
  • Whole-Body Irradiation

Substances

  • Adjuvants, Immunologic
  • Peptides
  • Thymus Extracts
  • Butylated Hydroxytoluene
  • Thymosin
  • T-activin